logo
logo

Quanterix Corporation acquires Akoya Biosciences

Jul 08, 2025•10 days ago

Acquiring Company

Quanterix

Acquired Company

Akoya Biosciences

BillericaMarlboroughHealth CareBioinformaticsGeneticsHealth DiagnosticsBiotechnology

Description

Quanterix Corporation has completed a $20 million acquisition of Akoya Biosciences. This strategic move aims to bolster their capabilities in biotechnology research. The acquisition strengthens their portfolio in the life sciences sector.

Company Information

Company

Quanterix

Location

900 MIDDLESEX TURNPIKE

Billerica, Massachusetts, United States

About

Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Masoud hidden

hidden
hidden

Vandana hidden

hidden
hidden